Publications
-
The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life.
Kwan JW,
Cronkite RC, Yiu A, Goldstein MK, Kazis L, Cheung RC.
Qual Life Res.
2008;
17
(5):
715-24
-
A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C.
Huang H,
Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC.
Hepatology.
2007;
46
(2):
297-306
-
Incidence of statin hepatotoxicity in patients with hepatitis C.
Khorashadi S,
Hasson NK, Cheung RC.
Clin Gastroenterol Hepatol.
2006;
4
(7):
902-7; quiz 806
-
Epidemiology of hepatitis C virus infection in American veterans.
Cheung RC,
Am J Gastroenterol.
2000;
95
(3):
740-7
-
Assessment and utilization of rapid virologic response in US veterans with chronic hepatitis C: evaluating provider adherence to practice guidelines.
Hwang EW,
Thomas IC, Cheung R, Backus LI.
J Clin Gastroenterol.
2013;
47
(3):
264-70
-
Implications of rapid virological response in hepatitis C therapy in the US veteran population.
Hwang EW,
Thomas IC, Cheung R, Backus LI.
Aliment Pharmacol Ther.
2012;
35
(1):
105-15
-
Tenofovir monotherapy and tenofovir plus entecavir combination as rescue therapy for entecavir partial responders.
Yip B,
Chaung K, Wong CR, Trinh HN, Nguyen HA, Ahmed A, Cheung R, Nguyen MH.
Dig Dis Sci.
2012;
57
(11):
3011-6
-
Utilization and antiviral therapy in patients with chronic hepatitis C: analysis of ambulatory care visits in the US.
Cheung R,
Mannalithara A, Singh G.
Dig Dis Sci.
2010;
55
(6):
1744-51
-
Adenovirus-induced acute liver failure.
Rothenberg M,
Cheung R, Ahmed A.
Dig Dis Sci.
2009;
54
(2):
218-21
-
Can we predict the degree of fibrosis in chronic hepatitis C patients using routine blood tests in our daily practice?
Cheung RC,
Currie S, Shen H, Bini EJ, Ho SB, Anand BS, Hu KQ, Wright TL, Morgan TR.
J Clin Gastroenterol.
2008;
42
(7):
827-34
-
Diagnostic markers for hepatitis virus infection
Charuworn P,
Cheung RC.
Expert Opinion Med Diagnostics.
2008:
2
303-314
-
Monitoring of epithelial cell caspase activation via detection of durable keratin fragment formation.
Tao GZ,
Li DH, Zhou Q, Toivola DM, Strnad P, Sandesara N, Cheung RC, Hong A, Omary MB.
J Pathol.
2008;
215
(2):
164-74
-
Persistence with hepatitis C therapy in the Department of Veterans Affairs.
Iqbal SU,
Cunningham F, Lee A, Miller DR, Li NC, Cheung R, Kazis L.
J Clin Pharm Ther.
2008;
33
(3):
251-61
-
Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 Study.
Tsui JI,
Currie S, Shen H, Bini EJ, Brau N, Wright TL.
Dig Dis Sci.
2008;
53
(3):
809-14
-
Clinical implications of hepatic steatosis in patients with chronic hepatitis C: a multicenter study of U.S. veterans.
Hu KQ,
Currie SL, Shen H, Cheung RC, Ho SB, Bini EJ, McCracken JD, Morgan T, Bräu N, Schmidt WN, Jeffers L, Wright TL.
Dig Dis Sci.
2007;
52
(2):
570-8
-
Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
Seal KH,
Currie SL, Shen H, Anand BS, Bini EJ, Brau N, Jeffers L, Wright TL.
J Clin Gastroenterol.
2007;
41
(2):
199-205
-
Positive CAGE screen correlates with cirrhosis in veterans with chronic hepatitis C.
Kamal A,
Cheung R.
Dig Dis Sci.
2007;
52
(10):
2564-9
-
Alcohol use and treatment of hepatitis C virus: results of a national multicenter study.
Anand BS,
Currie S, Dieperink E, Bini EJ, Shen H, Ho SB, Wright T.
Gastroenterology.
2006;
130
(6):
1607-16
-
Black patients with chronic hepatitis C have a lower sustained viral response rate than non-Blacks with genotype 1, but the same with genotypes 2/3, and this is not explained by more frequent dose reductions of interferon and ribavirin*.
Bräu N,
Bini EJ, Currie S, Shen H, Schmidt WN, King PD, Ho SB, Cheung RC, Hu KQ, Anand BS, Simon FR, Aytaman A, Johnson DP, Awad JA, Ahmad J, Mendenhall CL, Pedrosa MC, Moseley RH, Hagedorn CH, Waters B, Chang KM, Morgan TR, Rossi SJ, Jeffers LJ, Wright TL.
J Viral Hepat.
2006;
13
(4):
242-9
-
Effectiveness of a screening program for hepatitis C.
Cheung RC,
Cunningham BA, Cooper AD.
Dig Dis Sci.
2006;
51
(5):
976-81
-
Global transcriptional response to interferon is a determinant of HCV treatment outcome and is modified by race.
He XS,
Ji X, Hale MB, Cheung R, Ahmed A, Guo Y, Nolan GP, Pfeffer LM, Wright TL, Risch N, Tibshirani R, Greenberg HB.
Hepatology.
2006;
44
(2):
352-9
-
Hepatitis B vaccines.
Yu AS,
Cheung RC, Keeffe EB.
Infect Dis Clin North Am.
2006;
20
(1):
27-45
-
Identification of two gene variants associated with risk of advanced fibrosis in patients with chronic hepatitis C.
Huang H,
Shiffman ML, Cheung RC, Layden TJ, Friedman S, Abar OT, Yee L, Chokkalingam AP, Schrodi SJ, Chan J, Catanese JJ, Leong DU, Ross D, Hu X, Monto A, McAllister LB, Broder S, White T, Sninsky JJ, Wright TL.
Gastroenterology.
2006;
130
(6):
1679-87
-
Phenotypic and functional status of intrahepatic T cells in chronic hepatitis C.
Wang J,
Holmes TH, de Guevara LL, Cheung R, Wright TL, He XS, Greenberg HB.
J Infect Dis.
2006;
194
(8):
1068-77
-
Screening for esophageal varices in cirrhotic patients: endoscope, platelet count, or both?
Charuworn P,
Cheung R.
Gastrointest Endosc.
2006;
64
(6):
865-7
-
The impact of chronic hepatitis C and comorbid psychiatric illnesses on health-related quality of life.
Lim JK,
Cronkite R, Goldstein MK, Cheung RC.
J Clin Gastroenterol.
2006;
40
(6):
528-34
-
A randomized, double-blind, placebo-controlled dose-escalation trial of merimepodib (VX-497) and interferon-alpha in previously untreated patients with chronic hepatitis C.
McHutchison JG,
Shiffman ML, Cheung RC, Gordon SC, Wright TL, Pottage JC, McNair L, Ette E, Moseley S, Alam J.
Antivir Ther.
2005;
10
(5):
635-43
-
Amantadine in treatment of chronic hepatitis C virus infection?
Lim JK,
Wooten D, Siegel R, Cheung RC.
J Viral Hepat.
2005;
12
(5):
445-55
-
Chronic hepatitis C in Latinos: natural history, treatment eligibility, acceptance, and outcomes.
Cheung RC,
Currie S, Shen H, Ho SB, Bini EJ, Anand BS, Bräu N, Wright TL.
Am J Gastroenterol.
2005;
100
(10):
2186-93
-
High mortality rate in patients with advanced liver disease independent of exposure to general anesthesia.
Cheung RC,
McAuley RJ, Pollard JB.
J Clin Anesth.
2005;
17
(3):
172-6
-
Prospective multicenter study of eligibility for antiviral therapy among 4,084 U.S. veterans with chronic hepatitis C virus infection.
Bini EJ,
Bräu N, Currie S, Shen H, Anand BS, Hu KQ, Jeffers L, Ho SB, Johnson D, Schmidt WN, King P, Cheung R, Morgan TR, Awad J, Pedrosa M, Chang KM, Aytaman A, Simon F, Hagedorn C, Moseley R, Ahmad J, Mendenhall C, Waters B, Strader D, Sasaki AW, Rossi S, Wright TL.
Am J Gastroenterol.
2005;
100
(8):
1772-9
-
Expression of chemokine receptors on intrahepatic and peripheral lymphocytes in chronic hepatitis C infection: its relationship to liver inflammation.
Wang J,
Holmes TH, Cheung R, Greenberg HB, He XS.
J Infect Dis.
2004;
190
(5):
989-97
-
Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX,
He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
J Med Virol.
2004;
72
(4):
575-85
-
Hepatitis B vaccines.
Yu AS,
Cheung RC, Keeffe EB.
Clin Liver Dis.
2004;
8
(2):
283-300
-
The use of class-I HLA tetramers for the detection of hepatitis C virus NS3-specific CD8(+) T cells in patients with chronic infection.
López-Labrador FX,
He XS, Berenguer M, Cheung RC, Wright TL, Greenberg HB.
J Immunol Methods.
2004;
287
(1-2):
91-9
-
Determination of hepatitis C virus genotype by Pyrosequencing.
Elahi E,
Pourmand N, Chaung R, Rofoogaran A, Boisver J, Samimi-Rad K, Davis RW, Ronaghi M.
J Virol Methods.
2003;
109
(2):
171-6
-
Interferon alfa regulated gene expression in patients initiating interferon treatment for chronic hepatitis C.
Ji X,
Cheung R, Cooper S, Li Q, Greenberg HB, He XS.
Hepatology.
2003;
37
(3):
610-21
-
The impact of hepatitis C status on postoperative outcome.
Cheung RC,
Hsieh F, Wang Y, Pollard JB.
Anesth Analg.
2003;
97
(2):
550-4, table of contents
-
Depression, anxiety, post-traumatic stress, and alcohol-related problems among veterans with chronic hepatitis C.
Lehman CL,
Cheung RC.
Am J Gastroenterol.
2002;
97
(10):
2640-6
-
Viral hepatitis and other infectious diseases in a homeless population.
Cheung RC,
Hanson AK, Maganti K, Keeffe EB, Matsui SM.
J Clin Gastroenterol.
2002;
34
(4):
476-80
-
Delayed fatal hemorrhage from pseudoaneurysm of the hepatic artery after percutaneous liver biopsy.
Ahmed A,
Samuels SL, Keeffe EB, Cheung RC.
Am J Gastroenterol.
2001;
96
(1):
233-7
-
Endoscopic gastrointestinal manifestations of liver disease.
Cheung RC,
Cooper S, Keeffe EB.
Gastrointest Endosc Clin N Am.
2001;
11
(1):
15-44
-
Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver.
Boisvert J,
He XS, Cheung R, Keeffe EB, Wright T, Greenberg HB.
J Infect Dis.
2001;
184
(7):
827-35
-
Treating chronic Hepatitis C patients with psychiatric disorders: an uphill battle.
Cheung R,
Ahmed A.
Am J Gastroenterol.
2001;
96
(1):
3-4
-
Management of gallstones and their complications.
Ahmed A,
Cheung RC, Keeffe EB.
Am Fam Physician.
2000;
61
(6):
1673-80, 1687-8
-
Quantitative analysis of hepatitis C virus-specific CD8(+) T cells in peripheral blood and liver using peptide-MHC tetramers.
He XS,
Rehermann B, López-Labrador FX, Boisvert J, Cheung R, Mumm J, Wedemeyer H, Berenguer M, Wright TL, Davis MM, Greenberg HB.
Proc Natl Acad Sci U S A.
1999;
96
(10):
5692-7
-
Finding the iron in the melting pot--practical use of a new genetic assay for hereditary hemochromatosis.
Glenn JS,
Cheung RC.
West J Med.
1998;
168
(6):
525-7
-
Hepatitis G virus: clinical relevance and responsiveness to interferon.
Cheung RC,
Keeffe EB.
Am J Gastroenterol.
1997;
92
(11):
1957-9
-
Hepatitis G virus: is it a hepatitis virus?
Cheung RC,
Keeffe EB, Greenberg HB.
West J Med.
1997;
167
(1):
23-33
-
Hepatitis C virus detection by single-round PCR specific for the terminal 3' noncoding region.
Umlauft F,
Wong DT, Oefner PJ, Underhill PA, Cheung RC, Wright TL, Kolykhalov AA, Gruenewald K, Greenberg HB.
J Clin Microbiol.
1996;
34
(10):
2552-8
-
A cell surface protein that binds avian hepatitis B virus particles.
Kuroki K,
Cheung R, Marion PL, Ganem D.
J Virol.
1994;
68
(4):
2091-6
-
Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses.
Dubuisson J,
Hsu HH, Cheung RC, Greenberg HB, Russell DG, Rice CM.
J Virol.
1994;
68
(10):
6147-60
-
Rapid and sensitive method for detection of hepatitis C virus RNA by using silica particles.
Cheung RC,
Matsui SM, Greenberg HB.
J Clin Microbiol.
1994;
32
(10):
2593-7
-
Screening and confirmatory testing of cadaver organ donors for hepatitis C virus infection: a U.S. National Collaborative Study.
Pereira BJ,
Wright TL, Schmid CH, Bryan CF, Cheung RC, Cooper ES, Hsu H, Heyn-Lamb R, Light JA, Norman DJ.
Kidney Int.
1994;
46
(3):
886-92
-
Longitudinal study of hepatitis C viremia in chronic hepatitis C.
Cheung RC,
Chan RT, Lok AS.
J Med Virol.
1993;
41
(4):
338-42
-
Hepatitis C viremia in patients with hepatitis C virus infection.
Lok AS,
Cheung R, Chan R, Liu V.
Hepatology.
1992;
15
(6):
1007-12
-
Peptide mapping of neutralizing and nonneutralizing epitopes of duck hepatitis B virus pre-S polypeptide.
Yuasa S,
Cheung RC, Pham Q, Robinson WS, Marion PL.
Virology.
1991;
181
(1):
14-21
-
Epitope-specific antibody response to the surface antigen of duck hepatitis B virus in infected ducks.
Cheung RC,
Trujillo DE, Robinson WS, Greenberg HB, Marion PL.
Virology.
1990;
176
(2):
546-52
-
Epitope mapping of neutralizing monoclonal antibodies against duck hepatitis B virus.
Cheung RC,
Robinson WS, Marion PL, Greenberg HB.
J Virol.
1989;
63
(6):
2445-51
Help